The New Jersey Supreme Court has designated mounting litigation over the Johnson & Johnson antibiotic Levaquin as a mass tort and has assigned it to an Atlantic County, N.J., judge. The suits charge that the drug, which is prescribed for bacterial infections of the lungs, urinary tract and skin, has caused Achilles' tendon ruptures and other damage. Johnson & Johnson had supported mass-tort designation but asked for venue in Middlesex County, N.J., where its headquarters is located.
Litigation Over Johnson & Johnson Antibiotic Levaquin Designated N.J. Mass Tort
New Jersey Law Journal
July 6, 2009